Delivery Order SPE2DE21D7020-SPE2D626F830V

Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $3,868.90 by the Defense Health Agency's Medical Supply Chain division on December 5, 2025. This fixed-price contract with economic price adjustment provisions is designated as NC EMERGE MR 12MM and carries an ultimate completion date of December 12, 2025. The award was made without a small business set-aside, allowing Boston Scientific to compete on an unrestricted basis. This delivery order is issued against Boston Scientific's existing Blanket Purchase Agreement with the Defense Health Agency, a single-award indefinite delivery vehicle valued at $750,000 with a ceiling through March 30, 2030, which was established specifically for the provision of radiation treatment devices.

As the sole supplier under the BPA, Boston Scientific fulfills the Defense Health Agency's requirements for specialized radiation oncology equipment and related products, including yttrium-90 glass microspheres and radiopharmaceuticals used in cancer treatment across military healthcare facilities and Veterans Affairs medical centers. The BPA structure enables the Defense Health Agency to issue task orders and delivery orders on an as-needed basis, streamlining procurement of complex medical devices while maintaining supply chain continuity for critical treatment modalities. This delivery order represents a routine resupply action under the established vehicle, consistent with Boston Scientific's ongoing role as a critical supplier of advanced medical technologies to federal healthcare agencies.